Literature DB >> 7054211

Radioimmunoassay and metabolism of the catechol estrogen 2-hydroxyestradiol.

S Kono, G R Merriam, D D Brandon, D L Loriaux, M B Lipsett.   

Abstract

Plasma levels of 2-hydroxyestradiol (2-OHE2) were measured using a new RIA procedure. Values were below the detection limit of the assay (less than 10 pg/ml), except in the third trimester of pregnancy, when they rose to approximately 15 pg/ml. The infusion of 130 microgram/h purified 2-OHE2 elevated its plasma concentration to 155 pg/ml, consistent with a plasma MCR (MCRp) of approximately 20,000 liters/day. The infusion of [3H] 2-OHE2 to equilibrium and chromatographic separation of the extracted plasma metabolites yielded an MCRp of about 13,000 liters/day; the major plasma metabolite comigrated with 2-methoxyestradiol, and [3H] xi-methoxyestrone was also formed. The MCRp, of 2-OHE2 is approximately half that of 2-hydroxyestrone (2-OHE1), but much higher than those of other steroids. As is true for 2-OHE1, the clearance of 2-OHE2 must occur primarily in the blood compartment. Together, the measured MCRp values and estrogen receptor affinities of 2-OHE2 and 2-OHE1 predict a relative potency for effects upon gonadotropin secretion which is close to that observed in vivo.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7054211     DOI: 10.1210/jcem-54-1-150

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  3 in total

1.  Fluoroenzymatic cycling assay (FECA) for the determination of catechol estrogen monomethyl ethers in human urine.

Authors:  T Fotsis; H P Shah; M Härkönen; H Adlercreutz
Journal:  Neurochem Res       Date:  1987-06       Impact factor: 3.996

2.  Comparison of ex vivo inhibitory effect between 2-hydroxyestradiol and its 17-sulfate on rat hepatic microsomal lipid peroxidation.

Authors:  Kaori Takanashi; Yasunori Osanai; Takahiro Kyo; Itsuo Yoshizawa
Journal:  Lipids       Date:  2003-08       Impact factor: 1.880

Review 3.  Understanding of ROS-Inducing Strategy in Anticancer Therapy.

Authors:  Su Ji Kim; Hyun Soo Kim; Young Rok Seo
Journal:  Oxid Med Cell Longev       Date:  2019-12-18       Impact factor: 6.543

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.